Vioxx

( Reuters ) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude a long-running investigation into Merck's promotion of its one-time blockbuster drug, which was withdrawn from the market in September 2004 after being linked to heart risks. The Justice Department alleged that Merck promoted the drug for treating rheumatoid arthritis before...Read Full Story

( Reuters ) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude a long-running investigation into Merck's promotion of its one-time blockbuster drug, which was withdrawn from the market in September 2004 after being linked to heart risks. The Justice Department alleged that Merck promoted the drug for treating rheumatoid arthritis before...Read Full Story

( Reuters ) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude a long-running investigation into Merck's promotion of its one-time blockbuster drug, which was withdrawn from the market in September 2004 after being linked to heart risks. The Justice Department alleged that Merck promoted the drug for treating rheumatoid arthritis before...Read Full Story

BBC News Merck to Plead Guilty, Pay $950 Million in US Vioxx Probe BusinessWeek Nov. 22 (Bloomberg) -- Merck & Co., the second-largest US drugmaker, will pay $950 million and a unit of the company will plead guilty to a criminal charge to resolve a US probe of its sales of the painkiller Vioxx. ... Merck will pay $950M to settle Vioxx investigation The Associated Press Merck to pay about $950 million to settle US Vioxx charge Reuters Merck to Pay $950 Million to Settle Government's Vioxx...Read Full Story

Globe and Mail Merck to pay about $950 million to settle US Vioxx charge Reuters Bottles of the prescription arthritis and pain medication VIOXX sit on a shelf in New York, in a 2004 photo. (Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an ... Merck to Pay $950 Million in Vioxx Settlement Wall Street Journal Merck ordered to pay $950M fo Vioxx case CBS News Merck will pay $950M to settle Vioxx investigation...Read Full Story

( Reuters ) - The Food and Drug Administration has declined to approve an oral contraceptive and a glaucoma treatment being developed by Merck & Co Inc, but the drugmaker did not disclose details of the agency's concerns. Merck already sells both products in some overseas markets. The contraceptive, called NOMAC/E2, is a pill that combines two hormones. The glaucoma medicine, tafluprost, is also known by its brand name Saflutan. Merck buried mention of the two setbacks in a 62-page regulatory...Read Full Story

Globe and Mail Merck to Pay $950 Million to Settle Civil and Criminal Charges Over Vioxx Bloomberg Vehicles enter the campus of Merck headquarters in Whitehouse Station, New Jersey. Photographer: Emile Wamsteker/Bloomberg Merck & Co. (MRK), the second-largest US drugmaker, will pay $950 ... Merck ordered to pay $950M in Vioxx case CBS News Merck to Plead Guilty, Pay $950 Million in US Vioxx Probe BusinessWeek Merck will pay $950M to settle Vioxx investigation The Associated Press CNN...Read Full Story

BBC News Merck ordered to pay $950M in Vioxx case CBS News A pharmacist holds up a bottle of the arthritis drug Vioxx September 30, 2004 in New York City. (Spencer Platt/Getty Images) NEW YORK The US Department of Justice said Tuesday that drug maker Merck will pay $950 million to resolve investigations into ... Merck to Pay $950 Million to Settle Civil and Criminal Charges Over Vioxx Bloomberg Merck to Plead Guilty, Pay $950 Million in US Vioxx Probe BusinessWeek Merck will pay $950M to...Read Full Story

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday. The fine will conclude a long-running investigation into Merck's promotion of its one-time blockbuster drug, which was withdrawn from the market in September 2004 after being linked to heart risks. Read More... More on VideoRead Full Story

( Reuters ) - Merck & Co's <MRK.N> quarterly profit and sales beat forecasts as strong demand for the company's diabetes and asthma drugs offset a sharp decline for its Remicade arthritis drug. The No. 2 U.S. drugmaker said on Friday it earned $1.69 billion, or 55 cents per share, in the third quarter. That compared with $342 million, or 11 cents per share, in the year-ago period, when the company took several big charges. Excluding special items, Merck earned 94 cents per share. Analysts on...Read Full Story